VRx-3996

· Viracta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRx-3996, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies [Phase 1, Phase 2]

See pricing